174 filings
8-K
PGEN
Precigen, Inc.
30 Aug 24
Departure of Directors or Certain Officers
5:00pm
8-K
PGEN
Precigen, Inc.
14 Aug 24
Precigen Reports Second Quarter and First Half 2024 Financial Results and Business Updates
4:19pm
8-K
PGEN
Precigen, Inc.
9 Aug 24
Entry into a Material Definitive Agreement
9:04am
8-K
PGEN
Precigen, Inc.
6 Aug 24
Precigen Strategically Prioritizes Portfolio to Focus on First Potential Gene Therapy Launch
4:13pm
8-K
PGEN
Precigen, Inc.
5 Jul 24
Departure of Directors or Certain Officers
5:16pm
8-K
md6qim 9f
14 May 24
Precigen Reports First Quarter 2024 Financial Results and Business Updates
5:19pm
8-K
26hew8l0vr 74
19 Mar 24
Precigen Reports Full Year 2023 Financial Results and Business Updates
4:17pm
8-K
1dpccx z4cn06c8ij3
8 Feb 24
Departure of Directors or Certain Officers
4:25pm
8-K
0bqk37ikfra
8 Jan 24
Precigen Highlights Pipeline Updates to be Presented at the 42nd Annual J.P. Morgan Healthcare Conference
8:39am
8-K
rzx6x2q
9 Nov 23
Precigen Reports Third Quarter 2023 Financial Results and Progress of Clinical Programs
5:07pm
8-K
c3pkt7q
9 Aug 23
Results of Operations and Financial Condition
8:15am
8-K
nsadrwg6qm1jp wiy
9 Jun 23
Departure of Directors or Certain Officers
4:32pm
8-K
2bp xj2d7p6n8n
10 May 23
Precigen Reports First Quarter 2023 Financial Results and Business Updates
8:00am
8-K
j9l3285n
4 Apr 23
Entry into a Material Definitive Agreement
9:16pm
8-K
cg2p3
13 Mar 23
Regulation FD Disclosure
6:06am
8-K
llhu1yd
6 Mar 23
Precigen Reports Fourth Quarter and Full Year 2022 Financial Results and Business Updates
4:13pm
8-K
vpj4hf1h 8g2zq
27 Jan 23
Entry into a Material Definitive Agreement
8:31am
8-K
4pw9voqq7unij vncd
24 Jan 23
Results of Operations and Financial Condition
4:10pm
8-K
kw5fb0cvgoft1uv k2s
11 Jan 23
Precigen Provides Pipeline and Corporate Updates at the 41st Annual J.P. Morgan Healthcare Conference
7:01pm
8-K
npa zbtrmum6rz2k0hq
9 Nov 22
Precigen Reports Third Quarter 2022 Financial Results and Progress of Clinical Programs
4:14pm